Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Der Nervenarzt
Erschienen in: Der Nervenarzt 3/2017

14.03.2016 | Pruritus | Übersichten

Dermatologische Erkrankungen und ihre Bedeutung für die Psychiatrie

verfasst von: P. Mavrogiorgou, Prof. Dr. G. Juckel

Erschienen in: Der Nervenarzt | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Zusammenfassung

Der Zusammenhang zwischen Haut- und psychischen Erkrankungen tritt in der klinischen Praxis nicht selten auf, jedoch gibt es bis heute nur wenige Untersuchungen dazu, zu dem fehlen Kenntnisse über entsprechende bedingende neurobiologische und immunologische Mechanismen. Dabei können Veränderungen und Erkrankungen der Haut oftmals ein (frühes) Zeichen für eine psychische Störung sein. Im Sinne einer wahren „Psycho-Somatik“ sollten also Psychiater bestmöglich über diesen Zusammenhang Bescheid wissen. Diese Übersicht thematisiert die wichtigsten dermatologischen Diagnosen in Beziehung zu ihren jeweiligen psychischen Komorbiditäten und benennt die wichtigsten Aspekte bez. Epidemiologie, Symptomatik, Pathophysiologie und Behandlungsoptionen.
Literatur
1.
Katsarou-Katsari A, Filipou A, Theoharides TC (1999) Effect of stress and other psychological factors on the pathophysiology and treatment of dermatoses. Int J Immunopathol Pharmacol 12:7–11PubMed
2.
Zouboulis CC, Böhm M (2004) Neuroendocrine regulation of sebocytes: a pathogenetic link between stress and acne. Exp Dermatol 13:31–35PubMedCrossRef
3.
Arck PC, Slominski A, Theoharides TC, Peters EMJ, Paus R (2006) Neuroimmunology of stress: skin takes center stag. J Invest Dermatol 126:1697–1704PubMedPubMedCentralCrossRef
4.
Steinhoff M, Schauber J, Leyden JJ (2013) New insights into rosacea pathophysiology: a review of recent findings. J Am Acad Dermatol 69(Suppl 1):15–26CrossRef
5.
6.
Buske-Kirschbaum A (2009) Cortisol responses to stress in allergic children: interaction with the immune response. Neuroimmunomodulation 16:325–332PubMedCrossRef
7.
Slominski A, Zbytek B, Nikolakis G, Manna PR, Skobowiat C, Zmijewski M, Li W, Janjetovic Z, Postlethwaite A, Zouboulis CC, Tuckey RC (2013) Steroidgenesis in the skin: implications for local immune functions. J Steroid Biochem Mol Biol 137:107–123PubMedPubMedCentralCrossRef
8.
Gupta MA, Gupta AK (2003) Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol 4:833–842PubMedCrossRef
9.
Leon A, Levin EC, Koo YM (2013) Psychodermatology: an overview. Semin Cutan Med Surg 32:64–67PubMedCrossRef
10.
Wessely SC, Lewis GH (1989) The classification of psychiatric morbidity in attenders at a dermatology clinic. Br J Psychiatry 155:686–691PubMed
11.
Aktan S, Ozmen E, Sanli B (1998) Psychiatric disorders in patients attending a dermatology outpatient clinic. Dermatology 197:230–234PubMedCrossRef
12.
Picardi A, Abeni D, Melchi CF, Puddu P, Pasquini P (2000) Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 143:983–991PubMedCrossRef
13.
Koo J, Lebwohl A (2001) Psychodermatology: the mind and skin connection. Am Fam Physician 64:1873–1879PubMed
14.
Gieler U, Niemeier V, Kupfer J, Brosig B, Schill WB (2001) Psychosomatische Dermatologie in Deutschland. Eine Umfrage an 69 Hautkliniken. Hautarzt 52:104–110PubMedCrossRef
15.
Moftah NH, Kamel AM, Attia HM, El-Baz MZ, Abd El-Moty HM (2013) Skin diseases in patients with primary psychiatric conditions: A hospital based study. J Epidemiol Glob Health 3:131–138PubMedCrossRef
16.
Dalgard FJ, Gieler U, Tomas-Aragones L, Lien L, Poot F, Jemec GBE, Misery L, Szabo C, Linder D, Sampogna F, Evers AWM, Halvorsen JA, Balieva F, Szepietowski J, Romanov D, Marron SE, Altunay IK, Finlay AY, Salek SS, Kupfer J (2015) The psychological burden of skin diseases: A cross-sectional multicenter study among dermatological out patients in 13 European countries. J Invest Dermatol 135:984–991PubMedPubMedCentralCrossRef
17.
Mookhoeck EJ, Van De Kerkhof PC, Hovens JE, Brouwers JR, Loonen AJ (2010) Skin disorders in chronic psychiatric illness. J Eur Acad Dermatol Venereol 24:1151–1156CrossRef
18.
Mookhoeck EJ, Van De Kerkhof PC, Hovens JE, Brouwers JR, Loonen AJ (2011) Substantial skin disorders in psychiatric illness coincide with diabetes and addiction. J Eur Acad Dermatol Venereol 25:392–397CrossRef
19.
Makigami K, Ohtaki N, Yasumura S (2012) A 35-month prospective study on onset of scabies in a psychiatric hospital: discussion on patient transfer and incubation period. J Dermatol 39:160–163PubMedCrossRef
20.
Kawai M, Suzuki T, Hiruma M, Ikeda S (2014) A retrospective cohort study of tinea pedis and tinea unguium in inpatients in a psychiatric hospital. Med Mycol J 55:E35–41PubMedCrossRef
21.
Sheikhmoonesi F, Hajheidari Z, Masoudzadeh A, Mohammadpour RA, Mozaffari M (2014) Prevalence and severity of obsessive-compulsive disorder and their relationships with dermatological diseases. Acta Med Iran 52:511–514PubMed
22.
Demet MM, Deveci A, Taskin EO, Ermertcan AT, Yurtsever F, Deniz F, Bayraktar D, Ozturkcan S (2005) Obsessive-compulsive disorder in a dermatology outpatient clinic. Gen Hosp Psychiatry 27:426–430PubMedCrossRef
23.
Fineberg NA, O’Doherty C, Rajagopal S, Reddy K, Banks A, Gale TM (2003) How common is obsessive-compulsive disorder in a dermatology outpatient clinic? J Clin Psychiatry 64:152–155PubMedCrossRef
24.
Deutsche Dermatologische Gesellschaft (DDG) (Taube M) (2006) AWMF online-S2-Leitlinie Psychosomatische Dermatologie (Reg.Nr. 013/024)
25.
Yadav S, Narang T, Kumaran MS (2013) Psychodermatology: a comprehensive review. Indian J Dermatolgy Venereol Leprol 79:176–192CrossRef
26.
27.
28.
Poot F, Sampogna F, Onnis L (2007) Basic knowledge in psychodermatology. JEADV 21:227–234PubMed
29.
Brown GE, Malakouti M, Sorenson E, Gupta R, Koo JYM (2015) Psychodermatology. In: Balon R, Wise TN (Hrsg) Clinical challenges in the biopsychosocial interface. Update on psychsomatics for the 21st centrury, Bd. 34. Karger, Basel, S 123–134 (Adv Psychosom Med)CrossRef
30.
Chung WL, Ng SS, Koh MJA, Peh LH, Liu T (2012) A review of patients managed at acombined psychodermatology clinic: a Singapore experience. Singabore Med J 53:789–793
31.
Shenefelt PD (2011) Psychodermatological disorders: recognition and treatment. Int J Dermatol 50:1309–1322PubMedCrossRef
32.
Falkai P, Wittchen HU (Hrsg) (2014) Diagnostisches und Statistisches Manual Psychischer Störungen (DSM V). Hogrefe, Göttingen
33.
Dilling H, Freyberger HJ (Hrsg) (1999) Internationale Klassifikation psychischer Störungen (ICD-10). Hans Huber, Bern
34.
Willemsen R, Roseeuw D, Vanderlinden J (2008) Alexithymia and dermatology: the state of the art. Int J Dermatol 47:903–910PubMedCrossRef
35.
Sifneos PE (1973) The prevalence of “alexithymic” characteristics in psychosomatic patients. Psychother Psychosom 22:255–262PubMedCrossRef
36.
Dieris-Hirche J (2013) Psychosoziale Faktoren der Neurodermitis im Erwachsenenalter. Dissertation
37.
Saitta P, Keehan P, Yousif J, Way BV, Grekin S, Brancaccio R (2011a) An update on the presence of psychiatric comorbidities in Acne patients, Part 1: overwiew of prevalence. Cutis 88:33–40PubMed
38.
Saitta P, Keehan P, Yousif J, Way BV, Grekin S, Brancaccio R (2011b) An update on the presence of psychiatric comorbidities in Acne patients, Part 2: depression, anxiety and suicide. Cutis 88:90–97
39.
Fried RG, Wechsler A (2006) Psychological problems in the acne patient. Dermatol Ther 19:237–240PubMedCrossRef
40.
41.
Harth W, Gieler U (2006) Psychosomatische Dermatologie. Springer Medizin, Heidelberg
42.
43.
Schmitt J, Apfelbacher C, Chen CM, Romanos M, Sausenthaler S, Koletzko S, Bauer CP, Hoffmann U, Krämer U, Berdel D, von Berg A, Wichmann HE, Heinrich J, German Infant Nutrition Intervention Group (2010) Infant-onset eczema in relation to mental health problems advantage 10 years: results from a prospective birth cohort study (German Infant Nutrition Intervention; GINI plus). J Allergy Clin Immunol 125:404–410PubMedCrossRef
44.
Schmitt J, Chen CM, Apfelbacher C, Romanos M, Lehmann I, Herbarth O, Schaaf B, Krämer U, von Berg A, Wichmann HE, Heinrich J, LISA-plus study Group (2010) Infant eczema, infant sleeping problems, and mental health at 10 years of age: the prospective birth cohort study LISA plus. Allergy 66:404–411PubMedCrossRef
45.
Slattery MJ, Essex MJ, Paletz EM, Vaness ER, Infante M, Rogers GM, Gern JE (2011) Depression anxxiety and dermatologic quality of life in adolescents with atopic dermatitis. J Allergy Clin Immunol 128:668–671PubMedPubMedCentralCrossRef
46.
Slattery MJ, Essex MJ (2011) Specificity in the association of anxiety, depression and atopic disorders in a community sample of adolescents. J Psychiatr Res 45:788–795PubMedCrossRef
47.
48.
Schmitt J, Apfelbacher C, Heinrich J, Weidinger S, Romanos M (2013) Association of atopic eczema and attention-deficit/hyperactivity disorder-meta-analysis of epidemiologic studies. Z Kinder Jugendpsychiatr Psychother 41:35–42PubMedCrossRef
49.
Yaghmaie P, Koudelka CW, Simpson EL (2013) Mental health comorbidity in atopic dermatitis. J Allergy Clin Immunol 131:428–433PubMedCrossRef
50.
Buske-Kirschbaum A, Schmitt J, Plessow F, Romanos M, Weidinger S, Roessner V (2013) Psychoedocrine and psychoneuroimmunological mechanisms in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder. Psychoendocrinology 38:12–23CrossRef
51.
Cheng CM, Hsu JW, Huang KL, Bai YM, Su TP, Li CT, Yang AC, Chang WH, Chen TJ, Tsai SJ, Chen MH (2015) Risk developing major depressive disorder and anxiety disorders among adolescents and adults with atopic dermatitis: a nationwide longitudinal study. J Affect Disord 178:60–65PubMedCrossRef
52.
Dorst J, Seikowski K (2012) Skin, bonding and partnership in atopic dermatitis and psoriasis. Hautarzt 63:214–220PubMedCrossRef
53.
Dieris-Hirche J, Milch WE, Kupfer J, Leweke F, Gieler U (2012) Atopic dermatitis attachment and partnership: a psychodermatological case control-study of adult patients. Acta Derm Venereol 92:462–466PubMedCrossRef
54.
Senra MS, Wollenberg A (2014) Psychodermatological aspects of atopic dermatitis. Br J Dermatol 1:38–43CrossRef
55.
Dieris-Hirche J, Gieler U, Kupfer J, Milch WE (2009) Suicidal ideation, anxiety and depression in adult patients with atopic dermatitis. Hautarzt 60:641–646PubMedCrossRef
56.
Hashizume H, Takigawa M (2006) Anxiety in allergy and atopic dermatitis. Curr Opin Allergy Clin Immunol 6:335–339PubMedCrossRef
57.
Mina S, Jabeen M, Singh S, Verma R (2015) Gender differences in depression and anxiety among atopic dermatitis patients. Indian J Dermatol 60:211–219PubMedPubMedCentral
58.
Shenefelt PD (2008) Therapeutic management of psychodermatological disorders. Expert Opin Pharmacother 9:973–985PubMedCrossRef
59.
Strutton DR, Kowalski JW, Glaser DA, Stang PE (2004) US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from national survey. J Am Acad Dermatol 51:241–248PubMedCrossRef
60.
Mourikis I, Zervas I (2008) Disorders of sweating in psychiatry. Psychiatriki 19:59–72PubMed
61.
Gross KM, Schote AB, Schneider KK, Schulz A, Meyer J (2014) Elevated social stress levels and depressive symptoms in primary hyperhidrosis. PLOS ONE 9(3):e92412PubMedPubMedCentralCrossRef
62.
Hamm H, Naumann MK, Kowalski JW, Kütt S, Kozma C, Teale C (2006) Primary focal hyperhidrosis: disease characteristics and functional impairment. Dermatology 212(4):343–353PubMedCrossRef
63.
Vorkamp T, Foo FJ, Khan S, Schmitto JD, Wilson P (2010) Hyperhidrosis: evolving concepts and a comprehensive review. Surgeon 8:287–292PubMedCrossRef
64.
De Moura NB Junior, das-Neves-Pereira JC, de Oliveira FR, Jatene FB, Parra ER, Capelozzi VL, Wolosker N, de Campos JR (2013) Expression of atecylcholine and its receptor in human synthetic ganglia in primary hyperhidrosis. Ann Thorac Surg 95:465–470CrossRef
65.
Fineberg JP (2014) Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monamine neurotransmitter release. Pharmacol Ther 143(2):133–152CrossRef
66.
Higley MJ, Picciotto MR (2014) Neuromodulation by acetylcholine: examples from schizophrenia and depression. Curr Opin Neurobiol 29:88–95PubMedCrossRef
67.
Gordon JL, Girdler SS, Meltzer-Brody SE, Stika CS, Thurston RC, Clark CT, Prairie BA, Moses-Kolko E, Joffe H, Wisner KL (2015) Ovarian hormone fluctuation, neurosteroids, and HPA axis dysregulation in perimenopausal depression: a novel heuristic model. Am J Psychiatry 172(3):227–236PubMedPubMedCentralCrossRef
68.
Lessa L, Luz F, Rezende R, Duraes S, Harrison B, Menezes G, Fontenelle L (2014) The psychiatric facet of hyperhidrosis: demographics, disability, quality of life and associated psychopathology. J Psychiatr Prac 20(4):316–323CrossRef
69.
Davidson JR, Foa EB, Connor KM, Churchill LE (2002) Hyperhidrosis in social anxiety disorder. Prog Neuropsychopharmacol Biol Psychiatry 26:1327–1331PubMedCrossRef
70.
Ruchinskas RA, Narayan RK, Meagher RJ, Furukawa S (2002) The relationship of psychopathology and hyperhidrosis. Br J Dermatol 147(4):733–735PubMedCrossRef
71.
Hamm H (2014) Impact of hyperhidrosis on quality of life and its assessment. Dermatol Clin 32:467–476PubMedCrossRef
72.
Schneier FR, Heimberg RG, Liebowitz MR, Blanco C, Gorenstein LA (2012) Social anxiety and functional impairment in patients seeking surgical evaluation for hyperhidrosis. Compreh Psychiatr 53:1181–1186CrossRef
73.
74.
Kretzmer GE, Gelkopf M, Kretzmer G, Melamed Y (2008) Idiopathic pruritus in psychiatric inpatients: an explorative study. Gen Hosp Psychaity 30:344–348CrossRef
75.
Martin-Brufau R, Corbalan-Berna J, Ramirez-Andreo A, Brufau-Redondo C, Liminana-Gras R (2010) Personality differences between patients with lichen simplex chronicus and normal population. A study of pruritus. Eur J Dermatol 20(83):359–363PubMed
76.
Konuk N, Koca R, Atik L, Muhtar S, Atasoy N, Bostanci B (2007) Psychopathology, depression and dissociative experiences in patients with lichen simplex chronicus. Gen Hosp Psychiatry 29:232–235PubMedCrossRef
77.
Liao YH, Lin CC, Tsai PP, Shen WC, Sung FC, Kao CH (2014) Increased risk of lichen simplex chronicus in people with anxiety disorder. A nationwide population-based retrospective cohort study. Br J Dermatol 170:890–894PubMedCrossRef
78.
Brenaut E, Horreau C, Pouplard C, Barnetche T, Paul C, Richard MA, Joly P, Le Maitre A, Aractingi S, Aubin F, Cribier B, Jullien D, Ortonne JP, Misery L (2013) Alcohol consumtion and psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 27(Suppl 3):30–35PubMedCrossRef
79.
Adamzik K, McAleer MA, Kirby B (2013) Alcohol and psoriasis: sobering thoughts. Clin Exp Dermatol 38:819–822PubMedCrossRef
80.
Zou L, Lonne-Rahm SB, Helander A, Stokkeland K, Franck J, Nordlind K (2015) Alcohol intake measured by phosphatidylethanol in blood and the lifetime drinking history interview are correlated with the extent of psoriasis. Dermatology 230:375–380PubMedCrossRef
81.
Dowlatshahi EA, Wakkee M, Arends L, Nijsten T (2014) The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis. J Investigat Dermatol 134:1542–1551CrossRef
82.
Bangemann K, Schulz W, Wohlleben J, Weyergraf A, Snitjer I, Werfel T, Schmid-Ott G, Böhm D (2014) Depression und Angststörung bei Psoriasispatienten. Hautarzt 65:1056–1061PubMedCrossRef
83.
Martin-Brufau R, Romero-Brufau S, Martin-Gorgojo A, Brufau Redondo C, Corbalan J, Ulnik J (2015) Psoriasis lesions are associated with specific types of emotions. Emotional profile in psoriasis. Eur J Dermatol 25:329–334
84.
Garshick MK, Kimball AB (2015) Psoriasis and the life cycle of persistent life effects. Dermatol Clin 33:25–39PubMedCrossRef
85.
Schmitt JM, Ford DE (2007) Role of depression in quality of life for patients with psoriasis. Dermatology 215(1):17–27PubMedCrossRef
86.
Noormohammadpour P, Fakour Y, Nazemei MJ, Ehsani A, Gholamali F, Morteza A, Mokhtari L, Khosrovanmehr N (2015) Evaluation of some psychological factors in psoriatic patients. Iran J Psychiatry 10:37–42PubMedPubMedCentral
87.
Schmitt J, Wozel G, Garzarolli M, Viehweg A, Bauer M, Leopold K (2014) Effectiveness of interdisciplinary vs. dermatological care of moderate-to-severe psoriasis: a pragmatic randomized controlled trial. Acta Derm Venereol 94:192–197PubMedCrossRef
88.
Gupta MA, Gupta AK, Chen SJ, Johnson AM (2005) Comorbidity of rosacea and depression: an analysis of the National Ambulatory Medical care Survey and National hospital Ambulatory Care Survey-Outpatient Departement data collected by the U.S. National Center for Health Statistics from 1995-to 2002. Br J Dermatol 153:1176–1181PubMedCrossRef
89.
Spoendlin J, Bichsel F, Voegel JJ, Jick SS, Meier CR (2014) The association between psychiatric diseases, psychotropic drugs and the risk of incident rosacea. Br J Dermatol 170:878–883PubMedCrossRef
90.
Scharschmidt TC, Yost JM, Truong SV, Steinhoff M, Wang KC, Berger TG (2011) Neorogenic Rosacea: a distinct clinical subtype requiring a modified approach to treatment. Arch Dermatol 147:123–126PubMedPubMedCentralCrossRef
91.
Steinhoff M, Buddenkotte J, Aubert J, Sulk M, Novak P, Schwab V, Mess C, Cevikbas F, Rivier M, Carlavan I, Deret S, Rosignoli C, Metze D, Luger TA, Voegel JJ (2011) Clinical, cellular and molecular aspects in the pathophysiology of Rosacea. J Investig Dermatol Symp Proc 15:2–11PubMedPubMedCentralCrossRef
92.
Schwab V, Sulk M, Seeliger S, Novak P, Aubert J, Mess C, Rivier M, Carlavan I, Rossio P, Metze D, Buddenkotte J, Cevikbas F, Voegel JJ, Steinhoff M (2011) Neurovascular and neuroimmun aspects in the pathophysiology of Rosacea. J Investig Dermatol Symp Proc 15:53–62PubMedPubMedCentralCrossRef
93.
Elewski BE (2009) Safe and effective treatment of seborrheic dermatitis. Cutis 83(6):333–338PubMed
94.
Maietta G, Fornaro P, Rongioletti F, Rebora A (1990) Patients with mood depression have a high prevalence of seborrhoeic dermatitis. Acta Derm Venereol 70:432–434PubMed
95.
Cömert A, Akbas B, Kilic EZ, Akin Ö, Gökce E, Göktuna Z, Taskapan O (2013) Psychaitric comorbidities and alexithymia in patients with seborrheic dermatitis: a questionnaire study in Turkey. Am J Clin Dermatol 14:335–342PubMedCrossRef
96.
Misery L, Touboul S, Vincot C, Dutray S, Rolland-Jacob G, Consoli SG, Farcet Y, Feton-Danou N, Cardinaud F, Callot V, De la Chapelle C, Pomey-Rey D, Consoli SM, Pour le Group Psychodermatologie (2007) Stress and seborrheic dermatitis. Ann Dermatol Venereol 134:833–837PubMedCrossRef
97.
98.
99.
Harth W, Blume-Peytavi U (2013) Psychotrichology: psychosomatic aspects of hair diseases. JDDG. doi:10 1111/j.1610–0387.2012.o8034.xPubMed
100.
Wallengren J, Isaksson A (2007) Urticarial dermographism: clinical features and response to psychosocial stress. Acta Derm Venereol 87:493–498PubMedCrossRef
101.
Staubach P, Dechene M, Metz M, Magerl M, Siebenhaar F, Weller K, Zezula P, Eckhardt-Henn A, Maurer M (2011) High prevalence of mental disorders and emotional distress in patients with chronic spontaneous urticaria. Acta Derm Venereol 91:557–561PubMedCrossRef
102.
Calamita Z, Pela-Calamita AB (2013) Chronic spontaneous urticaria: epidemiological characteristics focusing on the histocompatibility profile and presence antibodies. Inflamm Allergy Drug Targets 12:8–11PubMedCrossRef
103.
Caffarelli C, Cuomo B, Cardinale F, Barberi S, Povesi Dascola C, Agostinis F, Franceschini F, Bernardini R (2013) Aetiological factors associated with chronic urticaria in children: a systematic review. Acta Derm Vener 93:268–272CrossRef
104.
Liu TH, Lin YR, Yang KC, Tsai YG, Fu YC, Wu TK, Wu HP (2010) Significant factors associated with severity and outcome of an initial episode of acute urticaria in children. Pediatr Allergy Immunol 21:1043–1051PubMedCrossRef
105.
Kuo CL, Chen CY, Huang HL, Chen WL, Lee HC, Chang CY, Chou CC, Ho SY, Wu HP, Lin YR (2014) Increased risk of major depression subsequent to a first-attack and non-infection caused urticaria in adolescence. A nationwide population.based study. BMC Pediatr 14:181–189PubMedPubMedCentralCrossRef
106.
107.
De Barros JC, Machado Filho CD, Abreu LC, de Barros JA, Paschoal FM, Nomura MT, Marques E, Martins LC (2014) A study of clinical profiles of vitiligo in different ages: an analysis of 669 outpatients. Int J Dermatol 53:842–848PubMedCrossRef
108.
Ahmed I, Ahmed S, Nasreen S (2007) Frequency and pattern of psychiatric disorders in patients with vitiligo. J Ayub Med Coll Abbottabad 19:19–21PubMed
109.
Lindhorst Homan MW, Spuls PI, de Korte J, Bos JD, Sprangers MA, van der Veen JP (2009) The burden of vitiligo: patient characteristics associated with quality of life. J Am Acad Dermatol 61:411–420CrossRef
110.
Wang KY, Wang KH, Zhang ZP (2011) Health-related quality of life and marital quality of vitiligo patients in China. J Eur Acad Dermatol Venereol 25:429–435PubMedCrossRef
111.
Karelson M, Silm H, Kingo K (2013) Quality of life and emotional state in vitiligo in an Estonia sample: comparison with psoriasis and healthy controls. Acta Derm Venereol 93:446–450PubMedCrossRef
112.
Papadopoulos L, Bor R, Legg C (1999) Coping with the disfiguring effects of vitiligo: A preliminary investigation into the effects of cognitive-behavioural therapy. Br J Med Psychol 72:385–396PubMedCrossRef
113.
Ruiz-Doblado S, Carrizosa A, Garcia-Hernandez MJ (2003) Alopecia areata: Psychiatric comorbidity and adjustment to illness. Int J Dermatol 42:434–437PubMedCrossRef
114.
Manolache L, Benea V (2007) Stress in patients with alopecia areata and vitiligo. J Eur Acad Dermatol Venereol 21:921–928PubMedCrossRef
115.
Grahovac T, Ruzic K, Sepic-Grahovac D, Dadic-Hero E, Radonja AP (2010) Depressive disorder and Alopecia. Psychiatr Danub 22(2):293–295PubMed
116.
Alfani S, Antinone V, Mozzetta A, DiPietro C, Mazzanti C, Stella P, Raskovich D, Abeni D (2012) Psychological status of patients with alopecia areata. Acta Derm Venereol 92:304–306PubMedCrossRef
117.
Abedini H, Farshi S, Mirabzadeh A, Keshavarz S (2014) Antidepressant effects of citalopram on treatment of alopecia areata in patients with major depressive disorder. J Dermatolog Treat 25:153–155PubMedCrossRef
118.
Jett K, Friedman JM (2010) Clinical and genetic aspects of neurofibromatosis 1. Genet Med 12(1):1–11PubMedCrossRef
119.
Belzeaux R, Lancon C (2006) Neurofibromatosis type 1: psychiatric disorders and quality of life impairment. Presse Med 35:277–280PubMedCrossRef
120.
Reichardt C, Scherwath A, Mautner VF, Bullinger M, Petersen-Ewert C (2013) Psychische Belastung von Erwachsenen mit Neurofibromatose Typ 1: Eine Längsschnittstudie. Psychother Psych Med 63:85–92CrossRef
121.
Koo J, Gambla C (1996) Delusions of parasitosis and other forms of monosymptomatic hypochondrial psychosis. General discussion and case illustrations. Dermatol Clin 14:429–438PubMedCrossRef
122.
123.
Yosipovitch G, Ishiuji Y, Patel TS, Hicks MI, Oshiro Y, Kraft RA, Winnicki E, Coghill RC (2008) The brain processing of scratching. J Investig Dermatol 128:1806–1811PubMedCrossRef
124.
Bin Saif GA, Ericson ME, Yosipivitch G (2011) The itchy scalp-scratching for an explanation. Exp Dermatol 20:959–968PubMedCrossRef
125.
Papoiu ADP, Nattkemper LA, Sanders KM, Kraft RA, Yiong-Huak C, Coghill RC, Yosipovitch G (2013) Brain’s reward circuits mediate itch relief. A functional MRI study of active scratching. PLOS ONE 8:e82389PubMedPubMedCentralCrossRef
126.
127.
Ständer S, Raap U, Weisshaar E, Schmelz M, Mettang T, Handwerker H, Luger TA (2011) Pathogenesis of pruritus. J Dtsch Dermatol Ges 9:456–463PubMed
128.
Ishuij Y, Coghill RC, Patel TS et al (2009) Distinct patterns of brain activity evoked by histamine-induced itch reveal an association with itch intensity and disease severity in atopic dermatitis. Br J Dermatol 161:1072–1080CrossRef
129.
Schneider G, Hockmann J, Stumpf A (2014) Psychosomatic aspects of prurigo nodularis. Hautarzt 65(8):704–708PubMedCrossRef
130.
Reiß M, Reiß G (2004) Das Burning Mouth Syndrom-Ursachen, Differentialdiagnose und Therapie. Ther Umsch 61:308–312PubMedCrossRef
131.
Coculescu EC, Tovaru S, Coculescu BI (2014) Epidemiological and etiological aspects of burning mouth syndrome. J Med Life 7(3):305–309PubMedPubMedCentral
132.
Trikkas C, Nikolatou O, Samara C, Bazopoulou-Kyrkanidou E, Rabavilas AD, Christodoulou GN (1996) Glossodynia: personality characteristics and psychopathology. Psychother Psychosom 65:163–168PubMedCrossRef
133.
Minguez-Sanz MP, Salort-Llorca C, Silvestre-Donat FJ (2011) Etiology of burning mouth syndrome: a review and update. Med Oral Patol Oral Cir Bucal 16:e1448
134.
Wong JW, Koo JYM (2013b) Psychopharmacological therapies in dermatology. Dermatol Online J 19:1–7
135.
Dadic-Hero E, Ruzic C, Grahovac T, Graovac M, Palijan TZ, Sepic-Grahovac D (2011) Allergic reactions outcome of sertraline and es-citalopram treatments. Psychiat Danubin 23:120–122
136.
Gross CM, Klöcker M, Jacob T, Klecha D (2009) Dermatologische Nebenwirkungen unter Therapie mit Serotonin-Noradrenalin-Wiederaufnahmehemmern. Nervenarzt 79:1304–1309CrossRef
137.
Diab M, Coloe J, Bechtel MA (2009) Bullous pemphigoid precipitated by galantamine hydrobromide. Cutis 83:139–140PubMed
138.
Ordonez L, Salgueiro E, Jimeno FJ, Manso G (2015) Spontaneous reporting of Steven-Johnson syndrome and toxic epidermal necrolysis associated with antiepileptic drugs. Eur Rev Med Pharmacol Sci 19:2732–2737PubMed
139.
Blaszczyk B, Lason W, Czuczwar SJ (2015) Antiepileptic drugs and adverse skin reactions: an update. Pharmacol Rep 67(3):426–434PubMedCrossRef
140.
Harth W, Seikowski K, Gieler U, Niemeier V, Hillert A (2007b) Psychopharmacological treatment of dermatological patients- when simply talking does not help. JDDG 12:1101–1107CrossRef
141.
Shukla R, Sasseville D (2008) Psychopharmacology in Psychodermatology. J Cut Med Surg 12:255–267CrossRef
Metadaten
Titel
Dermatologische Erkrankungen und ihre Bedeutung für die Psychiatrie
verfasst von
P. Mavrogiorgou
Prof. Dr. G. Juckel
Publikationsdatum
14.03.2016
Verlag
Springer Medizin
Schlagwörter
Pruritus
Hyperhidrose
Erschienen in
Der Nervenarzt / Ausgabe 3/2017
Print ISSN: 0028-2804
Elektronische ISSN: 1433-0407
DOI
https://doi.org/10.1007/s00115-016-0082-4

Weitere Artikel der Ausgabe 3/2017

Der Nervenarzt 3/2017 Zur Ausgabe

Übersichten

Leitliniengerechte psychiatrisch-psychotherapeutische Behandlung bei bipolaren Störungen

Aktuelles

Zur Legalisierungsdebatte des nichtmedizinischen Cannabiskonsums

Aktuelles

Implementierung stationsungebundener Leistungen in der Psychiatrie

Kurzbeiträge

Medikamentöse rückfallprophylaktische Behandlung der Alkoholabhängigkeit

Leserbriefe

Keine hochwertige Evidenz für Verhinderung von Suiziden durch Antidepressiva und Clozapin

Leserbriefe

Bessere Suizidprävention durch Konsiliarpsychiatrie in Allgemeinkrankenhäusern

Neu in den Fachgebieten Neurologie und Psychiatrie

25.04.2024 | Hypotonie | Nachrichten

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 | AAN-Jahrestagung 2024 | Nachrichten

Frühe Alzheimertherapie lohnt sich

25.04.2024 | Parkinson-Krankheit | Nachrichten

Viel Bewegung in der Parkinsonforschung

23.04.2024 | Demenz | Nachrichten

Demenzkranke durch Antipsychotika vielfach gefährdet